ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: Progresses and future directions

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used for mapping histone modifications, histone proteins, chromatin regulators, transcription factors and other DNA-binding proteins. It has played a significant role in our understanding of disease mechanisms and in exploring epigenetic changes for potential clinical applications. However, the conventional protocol requires large amounts of starting material and does not quantify the actual occupancy, limiting its applications in clinical settings. Herein we summarize the latest progresses in utilizing ChIP-seq to link epigenetic alterations to disease initiation and progression, and the implications in precision medicine. We provide an update on the newly developed ChIP-seq protocols, especially those suitable for scare clinical samples. Technical and analytical challenges are outlined together with recommendations for improvement. Finally, future directions in expediting ChIP-seq use in clinic are discussed.

Original languageEnglish (US)
Pages (from-to)1239-1258
Number of pages20
JournalEpigenomics
Volume8
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Precision Medicine
Chromatin Immunoprecipitation
Epigenomics
Histone Code
DNA-Binding Proteins
Histones
Chromatin
Disease Progression
Transcription Factors
Direction compound
Proteins

Keywords

  • cancer
  • ChIP-seq
  • chromatin
  • chromatin regulators
  • epigenetic drugs
  • histone modification
  • transcription factor binding

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine : Progresses and future directions. / Yan, Huihuang D; Tian, Shulan; Slager, Susan L; Sun, Zhifu D.

In: Epigenomics, Vol. 8, No. 9, 01.09.2016, p. 1239-1258.

Research output: Contribution to journalReview article

@article{88beaf3e85f442dc8f058cd2e0db1077,
title = "ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: Progresses and future directions",
abstract = "Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used for mapping histone modifications, histone proteins, chromatin regulators, transcription factors and other DNA-binding proteins. It has played a significant role in our understanding of disease mechanisms and in exploring epigenetic changes for potential clinical applications. However, the conventional protocol requires large amounts of starting material and does not quantify the actual occupancy, limiting its applications in clinical settings. Herein we summarize the latest progresses in utilizing ChIP-seq to link epigenetic alterations to disease initiation and progression, and the implications in precision medicine. We provide an update on the newly developed ChIP-seq protocols, especially those suitable for scare clinical samples. Technical and analytical challenges are outlined together with recommendations for improvement. Finally, future directions in expediting ChIP-seq use in clinic are discussed.",
keywords = "cancer, ChIP-seq, chromatin, chromatin regulators, epigenetic drugs, histone modification, transcription factor binding",
author = "Yan, {Huihuang D} and Shulan Tian and Slager, {Susan L} and Sun, {Zhifu D}",
year = "2016",
month = "9",
day = "1",
doi = "10.2217/epi-2016-0053",
language = "English (US)",
volume = "8",
pages = "1239--1258",
journal = "Epigenomics",
issn = "1750-1911",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine

T2 - Progresses and future directions

AU - Yan, Huihuang D

AU - Tian, Shulan

AU - Slager, Susan L

AU - Sun, Zhifu D

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used for mapping histone modifications, histone proteins, chromatin regulators, transcription factors and other DNA-binding proteins. It has played a significant role in our understanding of disease mechanisms and in exploring epigenetic changes for potential clinical applications. However, the conventional protocol requires large amounts of starting material and does not quantify the actual occupancy, limiting its applications in clinical settings. Herein we summarize the latest progresses in utilizing ChIP-seq to link epigenetic alterations to disease initiation and progression, and the implications in precision medicine. We provide an update on the newly developed ChIP-seq protocols, especially those suitable for scare clinical samples. Technical and analytical challenges are outlined together with recommendations for improvement. Finally, future directions in expediting ChIP-seq use in clinic are discussed.

AB - Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used for mapping histone modifications, histone proteins, chromatin regulators, transcription factors and other DNA-binding proteins. It has played a significant role in our understanding of disease mechanisms and in exploring epigenetic changes for potential clinical applications. However, the conventional protocol requires large amounts of starting material and does not quantify the actual occupancy, limiting its applications in clinical settings. Herein we summarize the latest progresses in utilizing ChIP-seq to link epigenetic alterations to disease initiation and progression, and the implications in precision medicine. We provide an update on the newly developed ChIP-seq protocols, especially those suitable for scare clinical samples. Technical and analytical challenges are outlined together with recommendations for improvement. Finally, future directions in expediting ChIP-seq use in clinic are discussed.

KW - cancer

KW - ChIP-seq

KW - chromatin

KW - chromatin regulators

KW - epigenetic drugs

KW - histone modification

KW - transcription factor binding

UR - http://www.scopus.com/inward/record.url?scp=84986910744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986910744&partnerID=8YFLogxK

U2 - 10.2217/epi-2016-0053

DO - 10.2217/epi-2016-0053

M3 - Review article

C2 - 27319740

AN - SCOPUS:84986910744

VL - 8

SP - 1239

EP - 1258

JO - Epigenomics

JF - Epigenomics

SN - 1750-1911

IS - 9

ER -